Randomized phase II study of vorinostat or placebo in combination with carboplatin and paclitaxel for patients with advanced or metastatic non-small cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 19 Dec 2012
At a glance
- Drugs Vorinostat (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 26 Apr 2011 New source identified and integrated (University of Southern California Norris Comprehensive Cancer Center; 2N10-3).
- 23 Nov 2009 Results published in the Journal of Clinical Oncology.
- 04 Aug 2009 Interim results presented at the 13th World Conference on Lung Cancer